Our Stories

“The courage it takes to share your story might be the very thing someone else needs to open their heart to hope.” — Unknown

Research Keeps Doctors Abreast of New Treatment Options

The doctors at The Texas Heart Institute Center for Cardiovascular Care work hard to stay abreast of the best available treatments and are often consulted for their expert opinions. Our connection to The Texas Heart Institute and its research gives us an edge. Many of the physicians and surgeons with The Center are active in research and publish their findings and opinions in the medical literature. In 2022, 46 research papers and editorials were published by our doctors in medical journals.

2022 Publications

1. M El Hajj and Z Krajcer. (2022) Percutaneous tricuspid valve repair: A safer alternative to traditional approaches? Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.30497

2. A Postalian. (2022) The “Pro-Seal” Large-Bore Arterial Access Closure Technique: Making the Best of What Is Available. Tex Heart Inst J. https://doi.org/10.14503/THIJ-22-7964

3. P Angelini. (2022) Acute, transient cardiomyopathy in patients with COVID-19: Can we clearly and quickly diagnose its cause and nature? Tex Heart Inst J. https://doi.org/10.14503/THIJ-22-7960

4. A Safdar, T Ahmed, VY Liu, A Addoumieh, AM Agha, DE Giza, DV Balanescu, T Donisan, T Dayah, JC Lopez-Mattei, PY Kim, S Hassan, K Karimzad, N Palaskas, JY Tsai, GD Iliescu, EH Yang, J Herrmann, K Marmagkiolis, P Angelini and CA Iliescu. (2022) Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med. https://doi.org/10.3389/fcvm.2022.1019284

5. S Zhang, S Liu, JP Leach, K Li, EC Perin and JF Martin. (2022) Gene therapy knockdown of hippo signaling resolves arrhythmic events in pigs after myocardial infarction. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.122.059972

6. L Golden and JG Rogers. (2022) Heart failure drug therapy: New treatments, new guidelines. Tex Heart Inst J. https://doi.org/10.14503/THIJ-22-7920

7. Z Krajcer. (2022) A minimalist transcatheter aortic valve replacement approach: Safety and effectiveness in real-world practice. Tex Heart Inst J. https://doi.org/10.14503/THIJ-22-7942

8. C de Oliveira Cardoso, A Elgalad, K Li and EC Perin. (2022) Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification. Front Cardiovasc Med. https://doi.org/10.3389/fcvm.2022.962839

9. A Postalian, S Kuchibhotla, S Koneru and NE Strickman. (2022) A special clinical scenario for transcatheter aortic valve replacement: “iatrogenic double-outlet” left ventricle. Tex Heart Inst J. https://doi.org/10.14503/THIJ-22-7889

10. M da Graca Cabreira, X Wang, A Critsinelis, M Setegne, P Lotfi, YW Wan, G Barrios, Z Mei, AP Gee, LM Buja and E Perin. (2022) Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signaling. Cytotherapy. https://doi.org/10.1016/j.jcyt.2022.06.005

11. GM Felker, P Buttrick, A Rosenzweig, ED Abel, LA Allen, M Bristow, S Das, AD DeVore, SG Drakos, JC Fang, JE Freedman, AF Hernandez, DY Li, TA McKinsey, C Newton-Cheh, JG Rogers, RV Shah, SH Shah, J Stehlik and CH Selzman. (2022) Heart Failure Strategically Focused Research Network: Summary of results and future directions. J Am Heart Assoc. https://doi.org/10.1161/JAHA.122.025517

12. A-TS Group, AJ Rogers, D Wentworth, A Phillips, K Shaw-Saliba, RL Dewar, NR Aggarwal, AG Babiker, W Chang, NJ Dharan, VJ Davey, ES Higgs, N Gerry, AA Ginde, JWA Hayanga, H Highbarger, JL Highbarger, MK Jain, V Kan, K Kim, P Lallemand, BG Leshnower, JK Lutaakome, G Matthews, A Mourad, E Mylonakis, V Natarajan, ML Padilla, LM Pandit, R Paredes, S Pett, S Ramachandruni, MT Rehman, BT Sherman, DC Files, SM Brown, MA Matthay, BT Thompson, JD Neaton, HC Lane and JD Lundgren. (2022) The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. Ann Intern Med. https://doi.org/10.7326/M22-0924

13. P Angelini. (2022) Can we talk? The residual questions about surgery for coronary artery anomalies. JTCVS Open. https://doi.org/10.1016/j.xjon.2022.04.001

14. A-TS Group, C Barkauskas, E Mylonakis, G Poulakou, BE Young, DM Vock, L Siegel, N Engen, G Grandits, NR Mosaly, AM Vekstein, R Rogers, F Shehadeh, M Kaczynski, EK Mylona, KN Syrigos, V Rapti, DC Lye, DS Hui, L Leither, KU Knowlton, MK Jain, R Marines-Price, A Osuji, JS Overcash, I Kalomenidis, Z Barmparessou, M Waters, K Zepeda, P Chen, S Torbati, F Kiweewa, N Sebudde, E Almasri, A Hughes, SR Bhagani, A Rodger, U Sandkovsky, RL Gottlieb, E Nnakelu, B Trautner, V Menon, J Lutaakome, M Matthay, P Robinson, K Protopapas, N Koulouris, I Kimuli, A Baduashvili, DL Braun, HF Gunthard, S Ramachandruni, R Kidega, K Kim, TJ Hatlen, AN Phillips, DD Murray, TO Jensen, ML Padilla, EX Accardi, K Shaw-Saliba, RL Dewar, M Teitelbaum, V Natarajan, S Laverdure, HC Highbarger, MT Rehman, S Vogel, D Vallee, P Crew, N Atri, AJ Schechner, S Pett, F Hudson, J Badrock, G Touloumi, SM Brown, WH Self, CM North, AA Ginde, CC Chang, A Kelleher, S Nagy-Agren, S Vasudeva, D Looney, HH Nguyen, A Sanchez, AC Weintrob, B Grund, S Sharma, CS Reilly, R Paredes, A Bednarska, NP Gerry, AG Babiker, VJ Davey, AC Gelijns, ES Higgs, V Kan, G Matthews, BT Thompson, P Legenne, R Chandra, HC Lane, JD Neaton and JD Lundgren. (2022) Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial. Ann Intern Med. https://doi.org/10.7326/M22-1503

15. P Angelini, B Marino and AF Corno. (2022) Single ventricle: amphibians and human beings. World J Pediatr. https://doi.org/10.1007/s12519-022-00595-5

16. K Li, A Elgalad, C Cardoso and EC Perin. (2022) Using the Apple Watch to record multiple-lead electrocardiograms in detecting myocardial infarction: Where are we now? Tex Heart Inst J. https://doi.org/10.14503/THIJ-22-7845

17. K Li, AM Segura, J Sun, Q Chen, J Cheng, EC Perin and A Elgalad. (2022) Rare delayed cardiac tamponade in a pig after cardiac surgery. Vet Med Sci. https://doi.org/10.1002/vms3.892

18. P AngeliniA PostalianE Hernandez-Vila, C Uribe and B Costello. (2022) COVID-19 and the heart: could transient takotsubo cardiomyopathy be related to the pandemic by incidence and mechanisms? Front Cardiovasc Med. https://doi.org/10.3389/fcvm.2022.919715

19. DM Farmer, JG Diez, V Orozco-Sevilla and JS Coselli. (2022) Use of a self-expanding transcatheter valve for a degenerated INTUITY valve. J Card Surg. https://doi.org/10.1111/jocs.16746

20. R Cogswell and JG Rogers. (2022) Residual heart failure on mechanically assisted circulation. JACC Heart Fail. https://doi.org/10.1016/j.jchf.2022.05.002

21. M Gyongyosi, E Pokushalov, A Romanov, E Perin, JM Hare, J Kastrup, F Fernandez-Aviles, R Sanz-Ruiz, A Mathur, W Wojakowski, E Martin-Rendon, N Pavo, IJ Pavo, R Hemetsberger, D Traxler, A Spannbauer and PM Haller. (2022) Meta-analysis of percutaneous endomyocardial cell therapy in patients with ischemic heart failure by combination of individual patient data (IPD) of ACCRUE and publication-based aggregate data. J Clin Med. https://doi.org/10.3390/jcm11113205

22. M Al Rifai, LK Newby, AP Nair, A Misra, JG Rogers, S Fedson and SS Virani. (2022) SGLT-2 inhibitors for patients with heart failure: what have we learned recently? Curr Atheroscler Rep. https://doi.org/10.1007/s11883-022-01038-2

23. P Angelini and C Uribe. (2022) Critical update and discussion of the prevalence, nature, mechanisms of action, and treatment options in potentially serious coronary anomalies. Trends Cardiovasc Med. https://doi.org/10.1016/j.tcm.2022.05.007

24. A Postalian and Z Krajcer. (2022) Mitral annular calcification-A marker of risk, and a harbinger of technical challenges during intervention. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.30216

25. P Shah and JG Rogers. (2022) Thrivival: Thriving and surviving for left ventricular assist device patients. JACC Heart Fail. https://doi.org/10.1016/j.jchf.2022.02.009

26. Z Krajcer. (2022) Artificial intelligence in cardiovascular medicine: Historical overview, current status, and future directions. Tex Heart Inst J. https://doi.org/10.14503/THIJ-20-7527

27. Z Krajcer. (2022) Artificial intelligence for education, proctoring, and credentialing in cardiovascular medicine. Tex Heart Inst J. https://doi.org/10.14503/THIJ-21-7572

28. SA Coulter and K Campos. (2022) Artificial intelligence in echocardiography. Tex Heart Inst J. https://doi.org/10.14503/THIJ-21-7671

29. MW Segar and Z Krajcer. (2022) Sex-based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.30196

30. S Kuchibhotla and Z Krajcer. (2022) Iso-osmolar versus low-osmolar contrast agents to reduce the incidence of renal and cardiovascular side effects. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.30170

31. RS Tobin, MF Cosiano, CM O’Connor, M Fiuzat, BB Granger, JG Rogers, JA Tulsky, KE Steinhauser and RJ Mentz. (2022) Spirituality in patients with heart failure. JACC Heart Fail. https://doi.org/10.1016/j.jchf.2022.01.014

32. KRW Matthews, O Kawam, K Sprung, EC Perin and Z Master. (2022) Role of physicians in guiding patients away from unproven stem cell interventions. Tex Heart Inst J. https://doi.org/10.14503/THIJ-21-7768

33. A Postalian and Z Krajcer. (2022) Facilitating future access to the coronary arteries in patients who need transcatheter aortic valve replacement: A significant step in the right direction. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.30124

34. JA Miranda, A Khouqeer, JJ Livesay and M Montero-Baker. (2022) Very late aortic endograft infection with listeria monocytogenes in an elderly man. Tex Heart Inst J. https://doi.org/10.14503/THIJ-20-7298

35. P Angelini, C Uribe and E Hernandez. (2022) Can ectopic right coronary from the left sinus have a different course than intramural? A case of ectopic right with retroaortic course. Cardiol Young. https://doi.org/10.1017/S1047951121004947

36. MR Ostovaneh, C Ward, B Ambale-Venkatesh, E Chamera, Y Kato, R Bolli, R Mitrani, EC Perin, TD Henry, JM Hare, L Moye, S Nazarian and JAC Lima. (2022) Reproducibility of cardiac magnetic resonance imaging in patients with cardiac implantable electrical devices: Multicenter CONCERT-HF Trial. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2021.11.023

37. V Jain, M Al Rifai, R Turpin, HN Eken, A Agrawal, D Mahtta, Z Samad, S Coulter, F Rodriguez, LA Petersen and SS Virani. (2022) Evaluation of factors underlying sex-based disparities in cardiovascular care in adults with self-reported premature atherosclerotic cardiovascular disease. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2021.5430

38. SC Silvestry and JG Rogers. (2022) Rinse, wash, repeat: The evolution of the UNOS heart transplant allocation system. JACC Heart Fail. https://doi.org/10.1016/j.jchf.2021.10.010

39. I Balachandran, OH Frazier and JG Rogers. (2022) Doing the wrong thing for the right reasons: The demise of the HVAD. J Thorac Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2021.10.058

40. RS Tobin, MD Samsky, M Kuchibhatla, CM O’Connor, M Fiuzat, HJ Warraich, KJ Anstrom, BB Granger, DB Mark, JA Tulsky, JG Rogers, RJ Mentz and KS Johnson. (2022) Race differences in quality of life following a palliative care intervention in patients with advanced heart failure: insights from the palliative care in heart failure trial. J Palliat Med. https://doi.org/10.1089/jpm.2021.0220

41. AS Rali, S Ranka, JA Mazurek, MD Brinkley, A Cedars, D Clark, N Do, GE Lazzara, L Punnoose, E Sandhaus, A Shah, S Taduru, M Wigger, S Zalawadiya, J Rogers, J Lindenfeld, K Schlendorf and JN Menachem. (2022) Exception-status listing: A critical pathway to heart transplantation for adults with congenital heart diseases. J Card Fail. https://doi.org/10.1016/j.cardfail.2021.10.004

42. BB Granger, JA Tulsky, BG Kaufman, RM Clare, K Anstrom, DB Mark, KA Johnson, CB Patel, M Fiuzat, K Steinhauser, C O’Connor, JG Rogers and RJ Mentz. (2022) Polypharmacy in palliative care for advanced heart failure: The PAL-HF experience. J Card Fail. https://doi.org/10.1016/j.cardfail.2021.08.021

43. P Angelini. (2022) Editorial commentary: Screening, preventing, treating coronary disease in young versus adult athletes: a complex discussion. Trends Cardiovasc Med. https://doi.org/10.1016/j.tcm.2021.09.005

44. GP Macaluso, FD Pagani, MS Slaughter, CA Milano, ED Feller, AJ Tatooles, JG Rogers and GM Wieselthaler. (2022) Time in therapeutic range significantly impacts survival and adverse events in destination therapy patients. ASAIO J. https://doi.org/10.1097/MAT.0000000000001572

45. DA Taylor, L Chacon-Alberty, LC Sampaio, MGD Hierro, EC Perin, FCP Mesquita, TD Henry, JH Traverse, CJ Pepine, JM Hare, MP Murphy, PC Yang, KL March, RW Vojvodic, RF Ebert, R Bolli and Cardiovascular Cell Therapy Research Network. (2022) Recommendations for nomenclature and definition of cell products intended for human cardiovascular use. Cardiovasc Res. https://doi.org/10.1093/cvr/cvab270

46. RJ Nuis, D Wood, H Kroon, M van Wiechen, D Bigelow, C Buller, J Daemen, P de Jaegere, Z Krajcer, J Webb and N Van Mieghem. (2022) Frequency, impact and predictors of access complications with plug-based large-bore arteriotomy closure – A patient level meta-analysis. Cardiovasc Revasc Med. https://doi.org/10.1016/j.carrev.2021.02.017